Biktarvy, formally known as biktarvy, includes a effective single-tablet regimen for treating HIV infection. This drug unites three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by preventing the virus's ability to multiply within the body, significantly lowering the viral quantity. For many individuals